|
ZNF415 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.542600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.975630E-02 |
| Normal-vs-Stage2 |
2.422300E-03 |
| Normal-vs-Stage3 |
1.157540E-02 |
| Normal-vs-Stage4 |
6.040400E-02 |
| Stage1-vs-Stage2 |
2.193400E-01 |
| Stage1-vs-Stage3 |
3.774800E-01 |
| Stage1-vs-Stage4 |
7.723600E-01 |
| Stage2-vs-Stage3 |
6.665800E-01 |
| Stage2-vs-Stage4 |
4.792200E-01 |
| Stage3-vs-Stage4 |
7.638200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.104800E-03 |
| Normal-vs-AfricanAmerican |
9.512100E-02 |
| Normal-vs-Asian |
2.666100E-02 |
| Caucasian-vs-AfricanAmerican |
4.256400E-01 |
| Caucasian-vs-Asian |
4.886400E-01 |
| AfricanAmerican-vs-Asian |
3.010800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.085000E-03 |
| Normal-vs-Female |
7.951000E-01 |
| Male-vs-Female |
2.597800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.278390E-01 |
| Normal-vs-Extreme_Weight |
2.043000E-03 |
| Normal-vs-Obese |
4.428400E-02 |
| Normal-vs-Extreme_Obese |
7.882000E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.389800E-01 |
| Normal_Weight-vs-Obese |
7.917800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.022800E-01 |
| Extreme_Weight-vs-Obese |
3.023800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.809600E-01 |
| Obese-vs-Extreme_Obese |
2.189200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.681200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.402300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.544100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.395200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.186600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.446000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.052400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.499200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.912020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.254800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.465880E-02 |
| Normal-VS-Type2 PRCC |
5.164100E-04 |
| Normal-VS-KIRP CIMP |
7.191000E-01 |
| Normal-VS-Unclassified PRCC |
2.044200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.117230E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.945600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.370800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.046400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.318600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.813500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.262200E-03 |
| Normal-vs-N1 |
9.316000E-02 |
| Normal-vs-N2 |
1.860490E-02 |
| N0-vs-N1 |
6.680000E-01 |
| N0-vs-N2 |
3.759000E-01 |
| N1-vs-N2 |
4.353600E-01 |
|
|
